Skip to content
Menu

PharmaCielo Ltd. PCLOF

Full chart Compare
Set alert

Price alert · PCLOF

All alert types
0.03 USD 0.00 (-8.57%)

Regular-session close

0.0148 Day range 0.0148
0.004 52-week range 0.117
YTD
-13.51%
1 year
+39.13%

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

-25.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -9.8×
P/S 3.7×
P/B -0.6×
P/FCF -10.8×
EV/EBITDA -21.7×
EV/Sales 10.7×
FCF Yield -9.2%

Profitability

Gross Margin 24.3%
Operating Margin -147.9%
Net Margin -153.0%
ROE 25.9%
ROIC -117.0%
ROA -46.5%

Growth (YoY)

Revenue -25.2%
Operating Income 21.5%
EPS (diluted) 90.0%
Free Cash Flow 55.3%

Financial Health

Current Ratio 0.2×
Quick Ratio 0.1×
Debt / Equity -1.2×
Net Debt / EBITDA -14.3×
Interest Coverage -1.5×

Dividends

Dividend Yield 0.0%
Payout Ratio 0.0%

Annual · latest fiscal year ends 2025-12-31